EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant Subunit Vaccine Candidate against the Bovine Viral Diarrhea Virus

Verónica Avello iD, Santiago Salazar iD, Eddy E González iD, Paula Campos, Viana Manríque iD, Christian Mathieu, Florence Hugues iD, Ignacio Cabezas iD, Paula Gädicke iD, Natalie C Parra, Jannel Acosta, Oliberto Sánchez und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Verónica Avello und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology and Biopharmaceuticals Laboratory, Pathophysiology Department, School of Biological Sciences, Universidad de Concepción, Víctor Lamas 1…. Hauptthemen laut MEDLINE: Viral Vaccines, Vaccines, Subunit, Antibodies, Viral, Vaccines, Synthetic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, Scientific and Technological Development Support Fund (FONDEF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multivalent live-attenuated or inactivated vaccines are often used to control the bovine viral diarrhea disease (BVD). Still, they retain inherent disadvantages and do not provide the expected protection. This study developed a new vaccine prototype, including the external segment of the E2 viral protein from five different subgenotypes selected after a massive screening. The E2 proteins of every subgenotype (1aE2, 1bE2, 1cE2, 1dE2, and 1eE2) were produced in mammalian cells and purified by IMAC. An equimolar mixture of E2 proteins formulated in an oil-in-water adjuvant made up the vaccine candidate, inducing a high humoral response at 50, 100, and 150 µg doses in sheep. A similar immune response was observed in bovines at 50 µg. The cellular response showed a significant increase in the transcript levels of relevant Th1 cytokines, while those corresponding to the Th2 cytokine IL-4 and the negative control were similar. High levels of neutralizing antibodies against the subgenotype BVDV1a demonstrated the effectiveness of our vaccine candidate, similar to that observed in the sera of animals vaccinated with the commercial vaccine. These results suggest that our vaccine prototype could become an effective recombinant vaccine against the BVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral VaccinesVaccines, SubunitAntibodies, ViralVaccines, SyntheticBovine Virus Diarrhea-Mucosal DiseaseAnimalsCattleAntibodies, NeutralizingSheepViral Envelope ProteinsCytokinesDiarrhea Viruses, Bovine ViralDiarrhea Virus 1, Bovine Viral

Stichwörter der Autor:innen

BVDV subgenotypesE2 glycoproteinbovine viral diarrhea virussubunit vaccine

Substanzen

Viral VaccinesVaccines, SubunitAntibodies, ViralVaccines, SyntheticAntibodies, NeutralizingViral Envelope ProteinsCytokines

Autor:innen und Institutionen

  • Biotechnology and Biopharmaceuticals Laboratory, Pathophysiology Department, School of Biological Sciences, Universidad de Concepción, Víctor Lamas 1290, Concepción P.O. Box 160C, Chile.
  • Department of Medicine, Division of Gastroenterology, Miller School of Medicine, University of Miami, Miami, FL 33146, USA.
  • Virology Section of the SAG's Sub-Department Network of Animal Health Laboratories, Lo Aguirre, Santiago de Chile 9020000, Chile.
  • Pathology and Preventive Medicine Department, School of Veterinary Sciences, Universidad de Concepción, Vicente Méndez 595, Chillán P.O. Box 537, Chile.
  • Pharmacology Department, School of Biological Sciences, Universidad de Concepción, Victor Lamas 1290, Concepción P.O. Box 160C, Chile.
  • Faculty of Basic Sciences, University of Medellin, Cra. 87 No 30-65, Medellin 050026, Colombia.

ORCID-Profile: Verónica Avello, Santiago Salazar, Eddy E González, Viana Manríque, Florence Hugues, Ignacio Cabezas, Paula Gädicke

Förderung

  • Fondo Nacional de Desarrollo Científico y Tecnológico
  • Scientific and Technological Development Support Fund (FONDEF)

Zitieren

APA

Avello, V., Salazar, S., González, E. E., Campos, P., Manríque, V., Mathieu, C., Hugues, F., Cabezas, I., Gädicke, P., Parra, N. C., Acosta, J., Sánchez, O., González, A., & Montesino, R. (2024). Recombinant Subunit Vaccine Candidate against the Bovine Viral Diarrhea Virus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168734

Vancouver

Avello V, Salazar S, González EE, Campos P, Manríque V, Mathieu C, et al. Recombinant Subunit Vaccine Candidate against the Bovine Viral Diarrhea Virus. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168734

BibTeX
@article{Avello2024,
  author = {Avello, Verónica and Salazar, Santiago and González, Eddy E and Campos, Paula and Manríque, Viana and Mathieu, Christian and Hugues, Florence and Cabezas, Ignacio and Gädicke, Paula and Parra, Natalie C and Acosta, Jannel and Sánchez, Oliberto and González, Alaín and Montesino, Raquel},
  title = {Recombinant Subunit Vaccine Candidate against the Bovine Viral Diarrhea Virus},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168734}
}
Kostenlos starten →